Biocryst Pharmaceuticals (BCRX) Long-Term Investments: 2010-2014
Historic Long-Term Investments for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $41.1 million.
- Biocryst Pharmaceuticals' Long-Term Investments rose 15723.51% to $47.8 million in Q3 2015 from the same period last year, while for Sep 2015 it was $47.8 million, marking a year-over-year increase of 15723.51%. This contributed to the annual value of $41.1 million for FY2014, which is 1492.41% up from last year.
- Biocryst Pharmaceuticals' Long-Term Investments amounted to $41.1 million in FY2014, which was up 1,492.41% from $2.6 million recorded in FY2013.
- In the past 5 years, Biocryst Pharmaceuticals' Long-Term Investments ranged from a high of $41.1 million in FY2014 and a low of $1.2 million during FY2012.
- In the last 3 years, Biocryst Pharmaceuticals' Long-Term Investments had a median value of $2.6 million in 2013 and averaged $14.9 million.
- Per our database at Business Quant, Biocryst Pharmaceuticals' Long-Term Investments slumped by 92.52% in 2012 and then spiked by 1,492.41% in 2014.
- Yearly analysis of 5 years shows Biocryst Pharmaceuticals' Long-Term Investments stood at $11.8 million in 2010, then skyrocketed by 30.68% to $15.4 million in 2011, then slumped by 92.52% to $1.2 million in 2012, then skyrocketed by 124.33% to $2.6 million in 2013, then spiked by 1,492.41% to $41.1 million in 2014.